These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22221844)

  • 1. Factors for life: advances in the treatment of congenital and coagulopathic bleeding disorders.
    Pipe S; Zieger B
    Thromb Res; 2011; 128 Suppl 1():S1. PubMed ID: 22221844
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant biologics for treatment of bleeding disorders.
    Bishop P; Lawson J
    Nat Rev Drug Discov; 2004 Aug; 3(8):684-94. PubMed ID: 15286735
    [No Abstract]   [Full Text] [Related]  

  • 3. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.
    Keeling D; Tait C; Makris M
    Haemophilia; 2008 Jul; 14(4):671-84. PubMed ID: 18422612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis in congenital coagulation disorders: past, present and future.
    Mannucci PM
    Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s1-3. PubMed ID: 19105502
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardizing patient outcomes measurement to improve haemophilia care.
    Srivastava A; van den Berg HM
    Haemophilia; 2016 Sep; 22(5):651-3. PubMed ID: 27562189
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation and management of congenital bleeding disorders.
    Bhat R; Cabey W
    Emerg Med Clin North Am; 2014 Aug; 32(3):673-90. PubMed ID: 25060256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant blood coagulation factors].
    Bödeker B
    Pharm Unserer Zeit; 2006; 35(1):40-5. PubMed ID: 16465865
    [No Abstract]   [Full Text] [Related]  

  • 8. How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries.
    Karimi M; Ravanbod S; Cohan N; Ala F
    Haemophilia; 2011 Jul; 17 Suppl 1():42-4. PubMed ID: 21692929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUHASS: The European Haemophilia Safety Surveillance system.
    Makris M; Calizzani G; Fischer K; Gilman EA; Hay CR; Lassila R; Lambert T; Ludlam CA; Mannucci PM
    Thromb Res; 2011 Jan; 127 Suppl 2():S22-5. PubMed ID: 21193110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies.
    Todd T; Perry DJ
    Haemophilia; 2010 Jul; 16(4):569-83. PubMed ID: 19906159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrate (PCC) for the treatment of coagulopathy associated with massive bleeding.
    Grottke O; Rossaint R
    Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S23-4. PubMed ID: 21598445
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation and Management of Congenital Bleeding Disorders.
    Bhat R; Cabey W
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):1105-1122. PubMed ID: 29078926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of blood fractions in coagulation disorders.
    Biggs R
    Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic and therapeutic trends in blood coagulation and fibrinolysis.
    Heimburger N; Becker U; Stief T; Pelzer H
    Behring Inst Mitt; 1988 Apr; (82):1-15. PubMed ID: 3044335
    [No Abstract]   [Full Text] [Related]  

  • 15. 25 years of published and unpublished coagulation-therapy data for Haemate P.
    Schramm W
    Eur J Haematol Suppl; 2008 May; (70):1-2. PubMed ID: 18380870
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
    Richter K; Klingenberg K; Reinecke D
    Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment possibilities of acute hemorrhagic diatheses in the newborn].
    Sigg P
    Ther Umsch; 1968 Dec; 25(12):642-4. PubMed ID: 5729319
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of congenital bleeding disorders: future trends in management.
    DiMichele D; Mannucci P
    Thromb Res; 2009 Dec; 124 Suppl 2():S1. PubMed ID: 20109650
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to use deliberately the PPSB coagulant fraction].
    Soulier JP
    Presse Med (1893); 1966 Mar; 74(16):823-5. PubMed ID: 5907425
    [No Abstract]   [Full Text] [Related]  

  • 20. Replacement of specific coagulation factors in patients with burn: a review.
    Lavrentieva A
    Burns; 2013 Jun; 39(4):543-8. PubMed ID: 23312909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.